Comments include: CCEP, COO, GKOS, NXST & REGN.
| CCEP Coca-Cola Europacific Partners PLC ($91.79) - Food Beverages/Soap - Shares of CCEP broke a quadruple top at $92 to move back to a buy signal while setting new all-time highs. The strong 5 for 5’er has traded in a positive trend dating back to 2022 and it currently ranks in the top quintile of its sector matrix. Those wishing to add the stock could look to do so here given its acceptable overbought level of only 40%. |
| COO The Cooper Companies, Inc. ($68.28) - Healthcare - COO moved further down on Friday, breaking a double bottom at $78 and reaching an intraday low below $66. The 0 for 5’er has been on a market RS sell signal since 2021 and ranks in the bottom half of the healthcare sector matrix. The weekly OBOS indicates that the stock is in heavily oversold territory, so wait for the 10-week trading band to normalize before selling your position. Initial resistance is at $82, with additional strong resistance at $85. |
| GKOS Glaukos Corp. ($94.29) - Healthcare - GKOS moved further down, breaking a double bottom at $93 and reaching an intraday low below $92. The 2 for 5’er shifted down from a 5 in February after moving into a negative trend and exhibiting short term relative weakness against both the market and its peers. Consider selling your position here. Long exposure should be avoided. Initial strong resistance is at $100, with additional resistance at $108. |
| NXST Nexstar Media Group Inc. ($170.59) - Media - NXST moved lower today, posting its first sell signal since the 2025 lows on its default chart. However, the sell signal does mark the sell signal of a bullish shakeout pattern. The action point here would come on a reversal back into X's at $174, so consider setting an alert for that point. From there, bulls will be interested to see how far bulls can take it, eying rangebound highs in the upper $180's... a mark roughly 9% away from our action point. |
| REGN Regeneron Pharmaceuticals, Inc. ($490.28) - Biomedics/Genetics - REGN reversed sharply into a column of Os on Friday, breaking a double bottom at $576 and reaching an intraday low below $488. REGN is a 0 for 5’er and ranks near the bottom of the biomedics/genetics sector matrix. The weekly OBOS indicates that the stock is in heavily oversold territory, so wait for the 10-week trading band to normalize before selling your position. Initial resistance is at $616. |
